Pharming PHAR
NASDAQ PHAR
$10.60 +0.95 (+9.84%)
At close: Oct 22, 2026 · 4:00 PM EDT

Pharming (PHAR) Net Debt Issuances and Repayments (2020 - 2024)

Updated

Analysis

Pharming (PHAR) Net Debt Issuances and Repayments (2020 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,142.38 Bn 1,110.97 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 635.12 Bn 554.98 Bn 17.30 Bn -4.36 Bn
3 AbbVie 500.65 Bn 473.76 Bn 12.70 Bn -2.00 Bn
4 Merck 355.26 Bn 309.64 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 300.41 Bn 264.40 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 263.79 Bn 237.48 Bn 12.86 Bn -2.46 Bn
7 Amgen 238.16 Bn 193.56 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -17.00 Mn
9 Pfizer 170.34 Bn 116.99 Bn 10.94 Bn 64.00 Mn
10 Pharming 788.65 Mn -5.72 Mn 141.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -134.92 Mn
Sep 30, 2024 -9,000.00
Jun 30, 2024 -134.92 Mn
Dec 31, 2020 -116.47 Mn
API Access

Pharming Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=PHAR&period=max&api_key=YOUR_API_KEY